References
- Agarwal SK, Sudhir SS, Sushma V, Sushil K. (2000). Antifungal activity of anthraquinone derivatives from Rheum emodi. J Ethnopharmacol, 72, 43–46.
- Bahorun T, Neergheen VS, Aruoma OI. (2005). Phytochemical constituents of Cassia fistula. Afr J Biotechnol, 4, 1530–1540.
- Breivik ON, Owades JL. (1957). Spectrophotometric semi-micro determination of ergosterol in yeast. J Agri Food Chem, 5, 360–363.
- CLSI/NCCLS. (2008). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-3rd edition. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
- Das S, Sarma G, Barman S. (2008). Hepatoprotective activity of aqueous extract of fruit pulp of Cassia fistula (AFCF) against carbon tetrachloride (CCL4) induced liver damage in albino rats. J Clin Diag Res, 2, 1133–1138.
- Dhar DN, Qasba GN. (1984). Screening of some plant extract for antifungal activity against Venturia inaequalis. Sci Cult, 50, 209.
- Duraipandiyan V, Ignacimuthu S. (2007). Antibacterial and antifungal activity of Cassia fistula L.: An ethnomedicinal plant. J Ethnopharmacol, 112, 590–594.
- Eggimann P, Garbino J, Pittet D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis, 3, 685–702.
- Elujoba AA, Abere AT, Adelusi SA. (1999). Laxative activities of Cassia pods sourced from Nigeria. Niger J Nat Prod Med, 3, 51–53.
- Ficker C, Smith ML, Akpagana K, Gbeassor M, Zhang J, Durst T, Assabgui R, Arnason JT. (2003). Bioassay-guided isolation and identification of antifungal compounds from ginger. Phytother Res, 17, 897–902.
- Gupta M, Mazumder UK, Rath N, Mukhopadhyay DK. (2000). Antitumor activity of methanolic extract of Cassia fistula L. seed against Ehrlich ascites carcinoma. J Ethnopharmacol, 72, 151–156.
- Gupta UC, Jain GC. (2009). Study on hypolipidemic activity of Cassia fistula legume in rats. Asian J Exp Sci, 23, 241–248.
- Harborne JB. (1973). Phytochemical Methods. Champan and Hall, London.
- Hatano T, Uebayashi H, Ito H, Shiota S, Tsuchiya T, Yoshida T. (1999). Phenolic constituents of Cassia seeds and antibacterial effect of some naphthalenes and anthraquinones on methicillin-resistant Staphylococcus aureus. Chem Pharm Bull, 47, 1121–1127.
- Ibrahim D, Osman H. (1995). Antimicrobial activity of Cassia alata from Malaysia. J Ethnopharmacol, 45, 151–156.
- Irshad M, Singh M, Rizvi MM. (2010). Assessment of anthelmintic activity of Cassia fistula L. Middle East J Sci Res, 5, 346–349.
- Kaleli I, Cevahir N, Demir M, Yildirim U, Sahin R. (2007). Anticandidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens. Mycoses, 50, 74–78.
- Kapadia GJ, Khorana ML. (1966). Studies of active constituents of Cassia fistula pulp. I. Colorimetric estimation of free rhein and combined sennidin-like compounds. Lloydia, 25, 55–58.
- Ken-Ichi F, Tomoko F, Isao K. (2008). Antifungal activity of alkanols against Zygosaccharomyces bailii and their effects on fungal plasma membrane. Phytother Res, 22, 1349–1355.
- Lupetti A, Danesi R, Campa M, Del Tacca M, Kelly S. (2002). Molecular basis of resistance to azole antifungals. Trends Mol Med, 8, 76–81.
- Mazumder UK, Malaya G, Nandita R. (1998). CNS activities of Cassia fistula in mice. Phytother Res, 12, 520–522.
- Michal T, Klaus PL. (2009). Potentilla-a review of its phytochemical and pharmacological profile. J Ethnopharmacol, 122, 184–204.
- Miyasaki Y, Nichols WS, Morgan MA, Kwan JA, Van Benschoten MM, Kittell PE, Hardy WD. (2010). Screening of herbal extracts against multi-drug resistant Acinetobacter baumannii. Phytother Res, 24, 1202–1206.
- Modi MRK, Khorana ML. (1952). A study of Cassia fistula pulp. Indian J Pharm, 61–63.
- Moshahid AR, Irshad M, Gamal EH, Salaem BY. (2009). Bioefficacies of Cassia fistula: An Indian labrum. Afr J Pharm Pharmacol, 3, 287–292.
- Perez RP, Godwin AK, Handel LM, Hamilton TC. (1993). A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Eur J Cancer, 29A, 395–399.
- Perumal SR, Ignacimuthu S, Sen A. (1998). Screening of 34 medicinal plants antibacterial properties. J Ethnopharmacol, 62, 173–182.
- Phongpaichit S, Pujenjob N, Rukachaisirikul V, Ongsakul M. (2004). Antifungal activity from leaf extracts of Cassia alata L., Cassia fistula L. and Cassia tora L. Songklanakarin J Sci Tech, 26, 741–748.
- Rex JH, Rinaldi MG, Pfaller MA. (1995). Resistance of Candida species to fluconazole. Antimicrob Agents Chemother, 39, 1–8.
- Siddhuraju P, Mohan PS, Becker K. (2002). Studies on the antioxidant activity of Indian laburnum (Cassia fistula L.): A preliminary assessment of crude extracts from stem bark, leaves, flowers and fruit pulp. J Agric Food Chem, 79, 61–67.
- Singh KN, Bharadwaj UR. (1975). Hypoglycaemic activity of Albizzia stipulata, Albizia moluccana and Cassia fistula leguminous seed diets on normal young rats. Indian J Pharm, 7, 47–49.
- Sofowora A. (1993). Medicinal Plants and Traditional Medicines in Africa. Chichester John Wiley & Sons, New York.
- Trease GE, Evans WC. (1978). Pharmacognosy. Bailliere Tindall Ltd, London.
- White A, Goetz MB. (1994). Azole-resistant Candida albicans: Report of two cases of resistance to fluconazole and review. Clin Infect Dis, 19, 687–692.